Stephen X. Skapek
- Oncology top 1%
- Cancer-related Molecular Pathways 17
-
- Sarcoma Diagnosis and Treatment 49
- Cancer Research top 2%
- Cancer-related molecular mechanisms research 7
-
- Tumors and Oncological Cases 23
- Rheumatology top 1%
- Soft tissue tumor case studies 10
-
- Ocular Oncology and Treatments 10
-
- Ubiquitin and proteasome pathways 6
- Epigenetics and DNA Methylation 6
- Co-authors
- Andrew B. LassarBennett G. NovitchDouglas S. HawkinsJames RheeGregory J. HannonOrna HalevyDavid BeachDouglas B. Spicer
- Journals
- Science (2 papers)Proceedings of the National Academy of Sciences (2 papers)Journal of Biological Chemistry (2 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Stephen X. Skapek
96 papers receiving 5.4k citations
Hit Papers
Peers
Comparison fields: 5 of 119
- Oncology 1.8k
- Pulmonary and Respiratory Medicine 1.9k
- Cancer Research 745
- Pathology and Forensic Medicine 888
- Rheumatology 702
Countries citing papers authored by Stephen X. Skapek
This map shows the geographic impact of Stephen X. Skapek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen X. Skapek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen X. Skapek more than expected).
Fields of papers citing papers by Stephen X. Skapek
This network shows the impact of papers produced by Stephen X. Skapek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen X. Skapek. The network helps show where Stephen X. Skapek may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Stephen X. Skapek, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 1 | |
| 2 | 2022 | 5 | |
| 3 | 2022 | 1 | |
| 4 | 2021 | 18 | |
| 5 | 2019 | 4 | |
| 6 | 2019 | 13 | |
| 7 | 2019 | 10 | |
| 8 | 2018 | 11 | |
| 9 | 2017 | 65 | |
| 10 | 2015 | 17 | |
| 11 | 2014 | 19 | |
| 12 | 2013 | 4 | |
| 13 | 2013 | 66 | |
| 14 | 2013 | 16 | |
| 15 | 2012 | 90 | |
| 16 | 2011 | 74 | |
| 17 | 2009 | 17 | |
| 18 | 2006 | 68 | |
| 19 | 2005 | 42 | |
| 20 | 1988 | 18 |
About Stephen X. Skapek
Stephen X. Skapek is a scholar working on Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Ophthalmology, having authored 97 papers that have together received 5.5k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (49 papers), Tumors and Oncological Cases (23 papers), Cancer-related Molecular Pathways (17 papers), Soft tissue tumor case studies (10 papers), Ocular Oncology and Treatments (10 papers), Cancer-related molecular mechanisms research (7 papers), Ubiquitin and proteasome pathways (6 papers) and Epigenetics and DNA Methylation (6 papers). The work is most often cited by research in Oncology (1.8k citations), Pulmonary and Respiratory Medicine (1.9k citations) and Cancer Research (745 citations). Stephen X. Skapek has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Andrew B. Lassar, Bennett G. Novitch, Douglas S. Hawkins, James Rhee, Gregory J. Hannon, Orna Halevy, David Beach, Douglas B. Spicer, Frederic G. Barr and Sheri L. Spunt. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.